Search Results 1041-1050 of 19905 for Receptor

1. Neuroendocrine tumors - Survival rates - Mayo Clinic

   Somatostatin receptors are found on the outside of many neuroendocrine tumor cells. Having cancer cells with somatostatin receptor type 2 (SSTR2) on their ...

2. Study To Evaluate Efficacy And Safety Of ONL1204 In Patients With GA Associated With AMD - Mayo Clinic

   ONL1204 is a first-in-class inhibitor of fragment apoptosis stimulator receptor-mediated cell death that has demonstrated protection of multiple retinal ...

3. Blood sugar levels can fluctuate for many reasons - Mayo Clinic

   Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin- ...

4. Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma - Mayo Clinic

   ... receptor (e.g., CTLA-4, OX 40, CD137); any other checkpoint inhibitor; bevacizumab; or any prior vaccine therapy. Note: Other inclusion and exclusion ...

5. Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents - Mayo Clinic

   The researchers measured nucleocapsid and spike protein S1 receptor-binding domain-specific immunoglobulin G antibodies in sera after participants completed the ...

6. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   Updated results from a phase 1 study (CRB-401) of idecabtagene vicleucel (ide-cel, bb2121), an anti-B cell maturation antigen (BCMA) chimeric antigen receptor ...

7. Renal artery stenosis - Diagnosis and treatment - Mayo Clinic

   Angiotensin-converting enzyme inhibitors, also called ACE inhibitors, and angiotensin II receptor blockers, also called ARBs. These medicines relax blood ...

8. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

   Cabozantinib S-malate is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may ...

9. Nesiritide in Resistant Hypertension - Clinical Trials

   ... receptor blocker (ARB) or calcium channel blocker (CCB). third line agent including one of the above and/or direct vasodilator, such as hydralazine or ...

10. Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia - Mayo Clinic

    Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by polymerase chain reaction (PCR). Patients must accept treatment and supportive care ...